Kestra Investment Management’s Gilead Sciences GILD Stock Holding History

Kestra Investment Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.13M	Sell	8,983 -4,953	-36%	-$653K	0.02%	212
2026 Q1	$1.94M	Buy	13,936 +3,221	+30%	+$451K	0.03%	136
2025 Q4	$1.32M	Buy	10,715 +412	+4%	+$50.1K	0.03%	173
2025 Q3	$1.14M	Sell	10,303 -2,044	-17%	-$232K	0.03%	186
2025 Q2	$1.37M	Buy	12,347 +10,949	+783%	+$1.17M	0.02%	232
2025 Q1	$157K	Sell	1,398 -2,391	-63%	-$247K	﹤0.01%	389
2024 Q4	$350K	Buy	3,789 +1,281	+51%	+$115K	0.01%	284
2024 Q3	$210K	Buy	+2,508	New	+$191K	0.01%	321

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Kestra Investment Management's GILD Position: Q2 2026 in Review

Kestra Investment Management reduced its Gilead Sciences (GILD) stake by 36% in Q2 2026, selling an estimated $653K and leaving 8,983 shares worth $1.13M. The position accounts for 0.02% of the portfolio, ranked #212.

Kestra Investment Management first reported a position in GILD in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.94M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Kestra Investment Management held 8,983 shares of Gilead Sciences worth $1.13M as of Q2 2026.
Kestra Investment Management sold 4,953 Gilead Sciences shares in Q2 2026, an estimated $653K.
Gilead Sciences made up 0.02% of Kestra Investment Management's portfolio in Q2 2026, its #212 holding.
Kestra Investment Management first reported a position in Gilead Sciences in Q3 2024 and has held it in 8 quarters since.
Kestra Investment Management's Gilead Sciences position peaked at $1.94M in Q1 2026.
2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Kestra Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.